Cargando…

288. Analysis of serum antibody response as correlates of protection against SARS-CoV-2 infection and the effects of BA.4/5 bivalent booster vaccination

BACKGROUND: Serum anti-spike IgG and neutralizing antibody against SARS-CoV-2 are recognized as immune correlates of protection (ICP) for COVID-19. However, there are limited data available on the ICP after the introduction of BA.4/5 bivalent vaccine. Thus, our study aimed to investigate the antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun Lim, So, Kim, Jineui, Kwon, Ji-Soo, Kang, Sung-Woon, Jin Chang, Eui, Bae, Seongman, Jae Kim, Min, Pil Chong, Yong, Lee, Sang-Oh, Choi, Sang-Ho, Park, Man-Seong, Kim, Sung-Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677580/ http://dx.doi.org/10.1093/ofid/ofad500.360

Ejemplares similares

Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

1467. Breakthrough Omicron Infections in Booster Vaccinated Healthcare Workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Antibody Response to Omicron BA.4–BA.5 Bivalent Booster
por: Wang, Qian, et al.
Publicado: (2023)

Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2023)

Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2022)

Comparison of the rapidity of SARS-CoV-2 immune responses between primary and booster vaccination for COVID-19
por: Kim, Ji Yeun, et al.
Publicado: (2022)

411. Comparison of clinical outcomes between early and delayed transplantation after SARS-CoV-2 infection
por: Reum Kim, A, et al.
Publicado: (2023)

Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection
por: Kang, Sung Woon, et al.
Publicado: (2022)

Corrigendum to “Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection” [J Infect 85 (2022) e69–e71]
por: Kang, Sung Woon, et al.
Publicado: (2023)

785. Bacterial Co-infection and Empirical Antibiotic Therapy in Patients with COVID-19
por: Lee, Jiyoung, et al.
Publicado: (2022)

No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies
por: Carreño, Juan Manuel, et al.
Publicado: (2023)

259. Comparison of the causes of death in patients with delta variant versus omicron variant infections
por: Reum Kim, A, et al.
Publicado: (2022)

Safety of BA.4-5 or BA.1 bivalent mRNA booster vaccines: nationwide cohort study
por: Andersson, Niklas Worm, et al.
Publicado: (2023)

Clinical scoring system to predict viable viral shedding in patients with COVID-19
por: Kang, Sung Woon, et al.
Publicado: (2022)

929. The different characteristics in renal impairment between severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome in South Korea
por: Ra, Sang Hyun, et al.
Publicado: (2023)

1357. Initial and Peak Serum Levels of Krebs von den Lungen-6 for Prediction of Prognosis in Patients with COVID-19
por: Kim, Geonui, et al.
Publicado: (2023)

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
por: Vasin, Andrey V, et al.
Publicado: (2023)

Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals
por: Jung, Jiwon, et al.
Publicado: (2022)

515. The Impact of Prolonged Steroid Use on Critically Ill COVID-19 Patients: A Retrospective Cohort Study
por: Han, Jaijun, et al.
Publicado: (2023)

214. Routine Ophthalmologic Examination in Klebsiella pneumoniae Bacteremia Is Not Necessary: Incidence of and Risk Factors for Ocular Involvement
por: Yun Lim, So, et al.
Publicado: (2023)

Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19
por: Bae, Seongman, et al.
Publicado: (2022)

Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
por: Springer, David N., et al.
Publicado: (2023)

Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023)

Correction to: Protracted course of SARS‑CoV‑2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023)

Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
por: Kim, A Reum, et al.
Publicado: (2023)

Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
por: Kawasuji, Hitoshi, et al.
Publicado: (2023)

Risk Factors for Mortality in Patients with Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae and Escherichia coli bacteremia
por: Seo, Hyeonji, et al.
Publicado: (2021)

61. Short- versus prolonged-courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection
por: Bae, Moonsuk, et al.
Publicado: (2021)

1082. Clinical Characteristics and Vertical Transmission of Pregnant Women with SARS-CoV-2 Infection and Their Neonates
por: Lee, Jiyoung, et al.
Publicado: (2022)

Clinical characteristics and outcomes of spontaneous bacterial peritonitis caused by Enterobacter species versus Escherichia coli: a matched case-control study
por: Bae, Seongman, et al.
Publicado: (2016)

Erratum to: Clinical characteristics and outcomes of spontaneous bacterial peritonitis caused by Enterobacter species versus Escherichia coli: a matched case-control study
por: Bae, Seongman, et al.
Publicado: (2016)

Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5
por: Fang, Zhenhao, et al.
Publicado: (2022)

Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19
por: Lee, Jiyoung, et al.
Publicado: (2023)

Clinical characteristics of COVID-19 rebound after nirmatrelvir-ritonavir or molnupiravir therapy: A prospective cohort study
por: Han, Jaijun, et al.
Publicado: (2023)

Clinical Sensitivity of the (1–3)-β-D-glucan Test for Predicting Candidemia
por: Lee, Yun Woo, et al.
Publicado: (2023)

Kinetics of Glycoprotein-Specific Antibody Response in Patients with Severe Fever with Thrombocytopenia Syndrome
por: Chung, Hyemin, et al.
Publicado: (2022)

2405. Clinical Characteristics and Prognostic Factors for Extraintestinal Infection Caused by Clostridium difficile: An Analysis of 62 Consecutive Cases
por: Chung, Hyemin, et al.
Publicado: (2019)

In Vitro Activities of Ceftazidime–Avibactam and Aztreonam–Avibactam at Different Inoculum Sizes of Extended-Spectrum β-Lactam-Resistant Enterobacterales Blood Isolates
por: Bae, Moonsuk, et al.
Publicado: (2021)

Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19
por: Bae, Seongman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o8ehaikjjdd3a02kdjs7342a2i